Peter Oppelt
Papers
1
Total Citations
5
H-Index
1
About
Dr. Peter Oppelt is a leading oncologist whose research focuses on optimizing treatment for human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC), a cancer with rising incidence. His major contribution lies in pioneering de-escalation strategies to reduce long-term toxicity without compromising survival. In his landmark non-randomized, multi-arm Phase 2 trial (2024), he demonstrated that risk-directed, de-escalated adjuvant therapy after surgery yields durable efficacy, sparing patients from aggressive radiation and chemotherapy side effects. This work, already cited 5 times, has reshaped clinical paradigms by proving that less can be more in HPV-driven cancers. Dr. Oppelt’s research integrates precision medicine with quality-of-life outcomes, earning him recognition as a thought leader in head and neck oncology. His findings are pivotal for young researchers exploring biomarker-driven treatment de-intensification, offering a model for balancing cure with survivorship. Through rigorous trial design and patient-centered endpoints, he continues to advance personalized cancer care.
Research Focus
Key Achievements
Top Papers
- 1